For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
XPeng Inc ADR (NYSE: XPEV) closed the day trading at $22.75 up 11.68% from the previous closing price of $20.37. In other words, the price has increased by $11.68 from its previous closing price. On the day, 32.57 million shares were traded. XPEV stock price reached its highest trading level at $23.27 during the session, while it also had its lowest trading level at $21.41.
Ratios:
For a better understanding of XPEV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.00 and its Current Ratio is at 1.14. In the meantime, Its Debt-to-Equity ratio is 1.01 whereas as Long-Term Debt/Eq ratio is at 0.36.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BNP Paribas Exane on August 18, 2025, initiated with a Neutral rating and assigned the stock a target price of $19.
On June 17, 2025, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $16.40 to $24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 18 ’24 when GGV (XPENG) LTD bought 303,680 shares for $12.71 per share.
GGV (XPENG) LTD bought 303,681 shares of XPEV for $3,897,472 on Dec 17 ’24. On Sep 04 ’24, another insider, GGV (XPENG) LTD, who serves as the Affiliate of the company, bought 408,506 shares for $8.52 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XPEV now has a Market Capitalization of 19704092672 and an Enterprise Value of 25277521920. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.12 while its Price-to-Book (P/B) ratio in mrq is 5.10. Its current Enterprise Value per Revenue stands at 0.419 whereas that against EBITDA is -8.646.
Stock Price History:
The Beta on a monthly basis for XPEV is 2.50, which has changed by 2.2453637 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, XPEV has reached a high of $27.16, while it has fallen to a 52-week low of $6.75. The 50-Day Moving Average of the stock is 20.32%, while the 200-Day Moving Average is calculated to be 29.51%.
Shares Statistics:
Over the past 3-months, XPEV traded about 7.19M shares per day on average, while over the past 10 days, XPEV traded about 12120610 shares per day. A total of 775.65M shares are outstanding, with a floating share count of 759.93M. Insiders hold about 2.27% of the company’s shares, while institutions hold 14.21% stake in the company. Shares short for XPEV as of 1753920000 were 35968441 with a Short Ratio of 5.00, compared to 1751241600 on 36495154. Therefore, it implies a Short% of Shares Outstanding of 35968441 and a Short% of Float of 4.77.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating for XPeng Inc ADR (XPEV) is a result of the insights provided by 3.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is $0.51, with high estimates of $0.76 and low estimates of $0.07.
Analysts are recommending an EPS of between -$0.4 and -$1.37 for the fiscal current year, implying an average EPS of -$0.89. EPS for the following year is $2.29, with 7.0 analysts recommending between $3.99 and $0.73.
Revenue Estimates
8 analysts predict $20.52B in revenue for the current quarter. It ranges from a high estimate of $21.19B to a low estimate of $19.77B. As of the current estimate, XPeng Inc ADR’s year-ago sales were $10.1BFor the next quarter, 8 analysts are estimating revenue of $24.88B. There is a high estimate of $27.21B for the next quarter, whereas the lowest estimate is $17.76B.
A total of 27 analysts have provided revenue estimates for XPEV’s current fiscal year. The highest revenue estimate was $89.18B, while the lowest revenue estimate was $71.13B, resulting in an average revenue estimate of $79.89B. In the same quarter a year ago, actual revenue was $40.87BBased on 37 analysts’ estimates, the company’s revenue will be $113.46B in the next fiscal year. The high estimate is $150.79B and the low estimate is $87.18B.
